Moreover, several studies are posing NF-κB as a key regulator in the cross-talk among the pathways leading to type 2 diabetes mellitus, inflammatory bowel diseases, and colorectal cancer [20]. This evidence concerns the gene NFKB1 and diabetes mellitus.